IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pharmstandard International S.A.

Q3 2018 Holdings

Filed 2018-11-15 | 7 holdings | $29.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Allena Pharmaceuticals(ALNAEUR)Common018119107$9.4K873,03132.3%
Protagonist Therapeutics, Inc.(PTGX)Common74366E102$7.7K750,63226.6%
Neon Therapeutics Inc.Common64050Y100$5.0K588,61117.3%
Jounce Therapeutics, Inc.(JNCEEUR)Common481116101$3.7K565,06312.6%
Proteon Therapeutics Inc.Common74371L109$3.1K1,607,80710.8%
Argos Therapeutics Inc.Common040221103$83826,1530.3%
Argos Therapeutics Inc.CallCommon040221103$26256,0300.1%